Page last updated: 2024-08-21

3-hydroxyflavone and Malignant Melanoma

3-hydroxyflavone has been researched along with Malignant Melanoma in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (6.25)29.6817
2010's14 (87.50)24.3611
2020's1 (6.25)2.80

Authors

AuthorsStudies
Banang-Mbeumi, S; Basnet, P; Boateng, ST; Chamcheu, JC; Chamcheu, RN; Chauvin, I; Fotie, J; Hill, RA; Kousoulas, KG; Ladu, F; Murru, S; Nagalo, BM; Roy, T; Sechi, M; Singh, PK; Spiegelman, VS; Walker, AL1
Chen, YM; Peng, Y; Sun, HY; Yue, JQ; Zhong, ZJ; Zhou, DZ1
Chien, HW; Hsieh, YH; Hu, DN; Lin, HW; Wang, K; Yang, SF; Yang, WE1
Afolabi, SO; Chiu, SY; Joshi, DC; Lall, RK; Mukhtar, H; Sechi, M; Singh, A; Syed, DN1
Afaq, F; Athar, M; Ballestas, ME; Elmets, CA; Katiyar, SK; Pal, HC; Sharma, S; Strickland, LR1
Adhami, VM; Chamcheu, JC; Khan, MI; Lall, RK; Mukhtar, H; Sechi, M; Syed, DN1
Chen, H; Li, M; Liu, B; Liu, J; Zeng, G; Zhang, Q; Zhu, R1
Im, SJ; Kim, JH; Kim, MY1
Deng, W; Guo, W; Qiu, H; Tang, R; Wang, J; Xiao, Y; Yi, C; Yu, W; Yu, Z; Yuan, Y; Zhang, Y1
Chamcheu, JC; Haidar, O; Lall, RK; Mukhtar, H; Syed, DN1
Afaq, F; Agarwal, J; Athar, M; Baxter, RD; Elmets, CA; Hunt, KM; Pal, HC1
Afaq, F; Athar, M; Diamond, AC; Elmets, CA; Kappes, JC; Katiyar, SK; Pal, HC; Strickland, LR1
Czyz, M; Gajos-Michniewicz, A1
Afaq, F; Ahmad, A; Johnson, JJ; Maddodi, N; Mukhtar, H; Sarfaraz, S; Setaluri, V; Syed, DN1
Arbiser, JL; Fisher, DE1
Bobet, R; Carilla, J; Cascante, M; Centelles, JJ; García, MT; Matito, C; Sort, X; Torres, JL; Varela, B1

Reviews

1 review(s) available for 3-hydroxyflavone and Malignant Melanoma

ArticleYear
Modulation of WNT/β-catenin pathway in melanoma by biologically active components derived from plants.
    Fitoterapia, 2016, Volume: 109

    Topics: Animals; Clinical Trials as Topic; Flavonoids; Flavonols; Humans; Melanoma; Pentacyclic Triterpenes; Phytochemicals; Quinazolines; Silymarin; Wnt Signaling Pathway

2016

Other Studies

15 other study(ies) available for 3-hydroxyflavone and Malignant Melanoma

ArticleYear
Synthesis, inverse docking-assisted identification and in vitro biological characterization of Flavonol-based analogs of fisetin as c-Kit, CDK2 and mTOR inhibitors against melanoma and non-melanoma skin cancers.
    Bioorganic chemistry, 2021, Volume: 107

    Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinase 2; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Flavonols; Humans; Melanoma; Molecular Docking Simulation; Molecular Structure; Proto-Oncogene Proteins c-kit; Skin Neoplasms; Structure-Activity Relationship; TOR Serine-Threonine Kinases; Tumor Cells, Cultured

2021
Dihydromyricetin induces apoptosis and cytoprotective autophagy through ROS-NF-κB signalling in human melanoma cells.
    Free radical research, 2017, Volume: 51, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Cytoprotection; Drug Screening Assays, Antitumor; Flavonols; Humans; Melanoma; NF-kappa B; Reactive Oxygen Species; Signal Transduction; Skin Neoplasms

2017
Fisetin induces apoptosis through mitochondrial apoptosis pathway in human uveal melanoma cells.
    Environmental toxicology, 2018, Volume: 33, Issue:5

    Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Cytochromes c; Flavonoids; Flavonols; Humans; Melanoma; Membrane Potential, Mitochondrial; Mitochondria; Proto-Oncogene Proteins c-bcl-2; Uveal Neoplasms

2018
Fisetin targets YB-1/RSK axis independent of its effect on ERK signaling: insights from in vitro and in vivo melanoma models.
    Scientific reports, 2018, 10-24, Volume: 8, Issue:1

    Topics: Antineoplastic Agents; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Epithelial-Mesenchymal Transition; Flavonoids; Flavonols; Humans; MAP Kinase Signaling System; Melanoma; Phosphorylation; Ribosomal Protein S6 Kinases, 90-kDa; Signal Transduction; Transcription, Genetic; Y-Box-Binding Protein 1

2018
Fisetin inhibits human melanoma cell invasion through promotion of mesenchymal to epithelial transition and by targeting MAPK and NFκB signaling pathways.
    PloS one, 2014, Volume: 9, Issue:1

    Topics: Antigens, CD; Antineoplastic Agents, Phytogenic; Cadherins; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Transdifferentiation; Drug Screening Assays, Antitumor; Flavonoids; Flavonols; Humans; MAP Kinase Signaling System; Melanoma; Neoplasm Invasiveness; NF-kappa B; Phosphorylation; Protein Processing, Post-Translational; Protein Transport; Vimentin

2014
Fisetin inhibits human melanoma cell growth through direct binding to p70S6K and mTOR: findings from 3-D melanoma skin equivalents and computational modeling.
    Biochemical pharmacology, 2014, Jun-01, Volume: 89, Issue:3

    Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Computer Simulation; Flavonoids; Flavonols; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Models, Biological; Protein Binding; Ribosomal Protein S6 Kinases, 70-kDa; TOR Serine-Threonine Kinases

2014
Dihydromyricetin induces cell cycle arrest and apoptosis in melanoma SK-MEL-28 cells.
    Oncology reports, 2014, Volume: 31, Issue:6

    Topics: Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Flavonols; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Neoplasm Proteins

2014
Evaluation of bioactive components and antioxidant and anticancer properties of citrus wastes generated during bioethanol production.
    Natural product communications, 2014, Volume: 9, Issue:4

    Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Biofuels; Carcinoma; Cell Line, Tumor; Cell Survival; Citrus; Colonic Neoplasms; Dose-Response Relationship, Drug; Ethanol; Flavanones; Flavonols; Humans; Melanoma; Solid Waste

2014
Melatonin enhances the anti-tumor effect of fisetin by inhibiting COX-2/iNOS and NF-κB/p300 signaling pathways.
    PloS one, 2014, Volume: 9, Issue:7

    Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Synergism; E1A-Associated p300 Protein; Flavonoids; Flavonols; Humans; Melanoma; Melatonin; NF-kappa B; Nitric Oxide Synthase Type II; Signal Transduction

2014
Involvement of ER stress and activation of apoptotic pathways in fisetin induced cytotoxicity in human melanoma.
    Archives of biochemistry and biophysics, 2014, Dec-01, Volume: 563

    Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Caspase 3; Cell Line, Tumor; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Flavonoids; Flavonols; Humans; Melanoma; Nitric Oxide; Reactive Oxygen Species; Signal Transduction

2014
Fisetin, a phytochemical, potentiates sorafenib-induced apoptosis and abrogates tumor growth in athymic nude mice implanted with BRAF-mutated melanoma cells.
    Oncotarget, 2015, Sep-29, Volume: 6, Issue:29

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Caspase 3; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Female; Flavonoids; Flavonols; Humans; Immunohistochemistry; Melanoma; Mice, Nude; Mitogen-Activated Protein Kinases; Mutation; Niacinamide; Phenylurea Compounds; Phosphatidylinositol 3-Kinases; Poly(ADP-ribose) Polymerases; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Sorafenib; Tumor Burden; Xenograft Model Antitumor Assays

2015
Fisetin, a dietary flavonoid, augments the anti-invasive and anti-metastatic potential of sorafenib in melanoma.
    Oncotarget, 2016, Jan-12, Volume: 7, Issue:2

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cadherins; Cell Line, Tumor; Cell Movement; Cells, Cultured; Drug Synergism; Epithelial-Mesenchymal Transition; Female; Flavonoids; Flavonols; Humans; Lung Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Melanoma; Mice, Nude; Mutation; Neoplasm Invasiveness; Niacinamide; Phenylurea Compounds; Proto-Oncogene Proteins B-raf; Sorafenib; Tumor Burden; Xenograft Model Antitumor Assays

2016
Inhibition of human melanoma cell growth by the dietary flavonoid fisetin is associated with disruption of Wnt/β-catenin signaling and decreased Mitf levels.
    The Journal of investigative dermatology, 2011, Volume: 131, Issue:6

    Topics: Animals; Antineoplastic Agents; beta Catenin; beta-Transducin Repeat-Containing Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Flavonoids; Flavonols; G1 Phase; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hepatocyte Nuclear Factor 1-beta; Humans; Melanoma; Mice; Microphthalmia-Associated Transcription Factor; Signal Transduction; Wnt Proteins

2011
Fisetin: a natural fist against melanoma?
    The Journal of investigative dermatology, 2011, Volume: 131, Issue:6

    Topics: Antineoplastic Agents; Flavonoids; Flavonols; Humans; Melanoma; Microphthalmia-Associated Transcription Factor; Proto-Oncogene Proteins B-raf

2011
Valorization of grape (Vitis vinifera) byproducts. Antioxidant and biological properties of polyphenolic fractions differing in procyanidin composition and flavonol content.
    Journal of agricultural and food chemistry, 2002, Dec-18, Volume: 50, Issue:26

    Topics: Antioxidants; Biflavonoids; Catechin; Cell Division; Chemical Fractionation; Chemical Phenomena; Chemistry, Physical; Cysteamine; Emulsions; Flavonoids; Flavonols; Free Radical Scavengers; Glycosylation; Humans; Lipid Peroxidation; Melanoma; Phenols; Plant Oils; Polymers; Proanthocyanidins; Tumor Cells, Cultured; Vitis

2002